Cumulative oral corticosteroid use increases risk of glucocorticoid-related adverse events in patients with newly diagnosed pemphigus.

REFERENCES 1. Yazdani Abyaneh MA, Griffith RD, Falto-Aizpurua L, Nouri K. Evaluation of sunscreens distributed by 2 major US retailers for meeting recommendations by the American Academy of Dermatology. J Am Acad Dermatol. 2014;71(5):1011-1012. 2. American Academy of Dermatology. How to select a sunscreen. Available at: https://www.aad.org/public/spot-skin-cancer/learnabout-skin-cancer/prevent/how-to-select-a-sunscreen. Accessed January 24, 2017. 3. Food and Drug Administration; Health and Human Services. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use. Final rule. Fed Regist. 2011; 76(117):35620-35665. 4. Wang SQ, Stanfield JW, Osterwalder U. In vitro assessments of UVA protection by popular sunscreens available in the United States. J Am Acad Dermatol. 2008;59(6):934-942.